NCT04576910View on ClinicalTrials.gov

Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China

PHASE4CompletedINTERVENTIONAL

Enrollment

387

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

December 31, 2021

Conditions

PolioVaccine Reaction

Interventions

BIOLOGICAL

vaccinated with Sabin IPV

the 4th dose of polio vaccination

BIOLOGICAL

vaccinated with bOPV

the 4th dose of polio vaccination

Trial Locations (2)

Unknown

Chunan center for disease control and prevention, Hangzhou

Longyou Center for Disease Control and Prevention, Quzhou

All Listed Sponsors

collaborator

China National Biotec Group Company ltd

UNKNOWN

lead

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

NCT04576910 - Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China | Biotech Hunter | Biotech Hunter